Correlation Between NetSol Technologies and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both NetSol Technologies and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NetSol Technologies and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NetSol Technologies and Carmell Therapeutics, you can compare the effects of market volatilities on NetSol Technologies and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NetSol Technologies with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NetSol Technologies and Carmell Therapeutics.
Diversification Opportunities for NetSol Technologies and Carmell Therapeutics
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between NetSol and Carmell is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding NetSol Technologies and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and NetSol Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NetSol Technologies are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of NetSol Technologies i.e., NetSol Technologies and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between NetSol Technologies and Carmell Therapeutics
Given the investment horizon of 90 days NetSol Technologies is expected to generate 0.2 times more return on investment than Carmell Therapeutics. However, NetSol Technologies is 4.92 times less risky than Carmell Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 219.00 in NetSol Technologies on November 3, 2024 and sell it today you would earn a total of 50.00 from holding NetSol Technologies or generate 22.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.6% |
| Values | Daily Returns |
NetSol Technologies vs. Carmell Therapeutics
Performance |
| Timeline |
| NetSol Technologies |
| Carmell Therapeutics |
NetSol Technologies and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NetSol Technologies and Carmell Therapeutics
The main advantage of trading using opposite NetSol Technologies and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NetSol Technologies position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.| NetSol Technologies vs. MIND CTI | NetSol Technologies vs. PDF Solutions | NetSol Technologies vs. Research Solutions | NetSol Technologies vs. Red Violet |
| Carmell Therapeutics vs. Ingredion Incorporated | Carmell Therapeutics vs. Vital Farms | Carmell Therapeutics vs. Flanigans Enterprises | Carmell Therapeutics vs. United Natural Foods |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |